[1] András Jánosi, Ferenc Péter Pach, Erds G, et al.Incidence, pre-hospital delay and prognosis of acute myocardial infarction in big regions of Hungary: Population data from the Hungarian myocardial infarction registry[J]. Int J Clin Pract, 2021, 75(11):e14831.
[2] Zhao J, Zeng Y, Shen X.Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta analysis[J]. Clin Cardiol, 2021, 44(10):1354-1359.
[3] 刘晓晨, 杨威. 急性心肌梗死患者血清尿酸, 转化生长因子β1, 糖类抗原12-5的表达水平及其联合预测新发房颤的价值[J]. 广西医学, 2022, 44(16): 1831-1835.
[4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会,《中国循环杂志》编辑委员会. 急性心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2001, 29(12):710-725.
[5] Zhang H, Zheng W, Wu S, et al.Analysis of potential factors contributing to refusal of invasive strategy after ST-segment elevation myocardial infarction in China[J]. Chin Med J (Engl), 2021, 134(5):524-531.
[6] 谢杰,李拥军.急性心肌梗死病人血清PLA2和Hcy水平与心室重构的关系[J]. 中西医结合心脑血管病杂志, 2021, 19(23): 4120-4123.
[7] 陈东,董玲玲,苏浩,等.高尿酸联合BNP, CRP, HCY可预测急性心肌梗死患者主要不良心血管事件[J]. 内科急危重症杂志, 2022, 28(6):504-507.
[8] 陈东,严激,陈康玉,等.高同型半胱氨酸与急性心肌梗死及短期心脏血管不良事件发生的相关性[J]. 安徽医药, 2021, 25(4): 760-763.
[9] 孙洪亮,朱虹,李鹏.血清CA-125联合TIMI危险评分对急性心肌梗死患者并发新发心房颤动的预测价值[J]. 山东医药, 2021, 61(34):24-28.
[10] 向祖琼,秦沛.血清CEACAM1, CA125与急性心肌梗死患者心功能及预后的关系分析[J].检验医学与临床, 2021, 22(4): 493-496. |
